Dong Yang

State-of-the-Art Strategies for Targeting RET-Dependent Cancers.

A. Drilon, F. Meric-Bernstam, V. Velcheti, 2020, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Natural Language Processing–Assisted Literature Retrieval and Analysis for Combination Therapy in Cancer

Md Abu Shufean, F. Meric-Bernstam, Jia Zeng, 2022, JCO clinical cancer informatics.

Identification of Actionable Genomic Alterations Using Circulating Cell-Free DNA.

Nora S. Sanchez, Ann M. Bailey, F. Meric-Bernstam, 2019, JCO precision oncology.

Genetic features and therapeutic relevance of emergent circulating tumor DNA alterations in refractory non-colorectal gastrointestinal cancers

L. Bucheit, P. Kasi, M. Beg, 2022, Nature Communications.

Sequential Combination Therapy of CDK Inhibition and Doxorubicin Is Synthetically Lethal in p53-Mutant Triple-Negative Breast Cancer

Xian Chen, K. Hunt, M. McArthur, 2016, Molecular Cancer Therapeutics.

CDK4/6 Inhibitors Sensitize Rb-positive Sarcoma Cells to Wee1 Kinase Inhibition through Reversible Cell-Cycle Arrest

K. Hunt, K. Keyomarsi, V. Ravi, 2017, Molecular Cancer Therapeutics.

Dual Roles of RNF2 in Melanoma Progression.

L. Chin, J. Ernst, E. Keung, 2015, Cancer discovery.

Operationalization of Next-Generation Sequencing and Decision Support for Precision Oncology.

Funda Meric-Bernstam, Jia Zeng, Amber Johnson, 2019, JCO clinical cancer informatics.

Molecular features and predictive models identify the most lethal subtype and a therapeutic target for osteosarcoma

Fei Wang, A. Sun, Dong Yang, 2023, Frontiers in Oncology.

OCTANE: Oncology Clinical Trial Annotation Engine.

Kenna R Mills Shaw, Funda Meric-Bernstam, Elmer V Bernstam, 2019, JCO clinical cancer informatics.

Targeting Replicative Stress and DNA Repair by Combining PARP and Wee1 Kinase Inhibitors Is Synergistic in Triple Negative Breast Cancers with Cyclin E or BRCA1 Alteration

Xian Chen, K. Hunt, A. Sahin, 2021, Cancers.